Jeffrey Girshman

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

Adam J. Schoenfeld, Kathryn C. Arbour, Hira Rizvi et al. · Annals of Oncology · 2019 · 413 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Membrane Stiffness and Channel Function

Jens A. Lundbæk, P. Birn, Jeffrey Girshman et al. · Biochemistry · 1996 · 315 citations

Natural Sciences, Biochemistry, Biophysics +17

Regulation of Sodium Channel Function by Bilayer Elasticity

Jens A. Lundbæk, P. Birn, Anker Jón Hansen et al. · The Journal of General Physiology · 2004 · 264 citations · Full text

Natural Sciences, Biophysics, Molecular Biology +17

CT-Guided Percutaneous Catheter Drainage of Acute Necrotizing Pancreatitis: Clinical Experience and Observations in Patients with Sterile and Infected Necrosis

Koenraad J. Mortelé, Jeffrey Girshman, Dênis Szejnfeld et al. · American Journal of Roentgenology · 2008 · 127 citations

Medicine, Surgery, Interventional Radiology +10

Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non–Small-Cell Lung Cancer

Natalie I. Vokes, David Liu, Biagio Ricciuti et al. · JCO Precision Oncology · 2019 · 120 citations · Full text

Medicine, Immunology, Oncology +17